Allogeneic disparities in immunoglobulin-like transcript 5 induce potent antibody responses in hematopoietic stem cell transplant recipients

Blood

Volumn 114, Issue 11, 2009, Pages 2323-2332

  Pfistershammer, Katharina ^a   Lawitschka, Anita ^b   Klauser, Christoph ^c   Leitner, Judith ^c   Weigl, Roman ^d   Heemskerk, Mirjam H M ^e   Pickl, Winfried F ^c   Majdic, Otto ^c   Böhmig, Georg A ^d   Fischer, Gottfried F ^d   Greinix, Hildegard T ^d   Steinberger, Peter ^c  

^a Universitatsklinik fur Dermatologie   (Austria)

^b ST ANNA CHILDREN S HOSPITAL   (Austria)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; IMMUNOGLOBULIN; IMMUNOGLOBULIN LIKE TRANSCRIPT 5; UNCLASSIFIED DRUG; ALLOANTIBODY; IMMUNOGLOBULIN RECEPTOR; LEUKOCYTE ANTIGEN; LILRB3 PROTEIN, HUMAN;

ACUTE GRAFT REJECTION; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANIMAL CELL; ANTIBODY RESPONSE; ARTICLE; CELL CLONING; CELL KILLING; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; EMBRYO; FEMALE; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HUMAN; HUMAN CELL; LEUKEMIA CELL; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROVIRUS; SERUM; ALLOTRANSPLANTATION; ANIMAL; ANTIBODY PRODUCTION; CLINICAL TRIAL; COLLAGEN DISEASE; FOLLOW UP; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOLOGY; MULTICENTER STUDY; PARITY; PREGNANCY; RETROSPECTIVE STUDY;

ANIMALS; ANTIBODY FORMATION; ANTIGENS, CD; COLLAGEN DISEASES; DENDRITIC CELLS; FEMALE; FOLLOW-UP STUDIES; GRAFT VS HOST DISEASE; GRAFT VS LEUKEMIA EFFECT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; ISOANTIBODIES; MALE; MICE; PARITY; PREGNANCY; RECEPTORS, IMMUNOLOGIC; RETROSPECTIVE STUDIES; TRANSPLANTATION, HOMOLOGOUS;

EID: 70349561841     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-10-183814     Document Type: Article

References (34)

1. Falkenburg JH, van de Corput L, Marijt EW, Willemze R. Minor histocompatibility antigens in human stem cell transplantation. Exp Hematol. 2003;31(9):743-751. (Pubitemid 37075966)
2. den Haan JM, Sherman NE, Blokland E, et al. Identification of a graft versus host disease-associated human minor histocompatibility antigen. Science. 1995;268(5216):1476-1480.
3. Pierce RA, Field ED, Mutis T, et al. The HA-2 minor histocompatibility antigen is derived from a diallelic gene encoding a novel human class I myosin protein. J Immunol. 2001;167:3223-3230. (Pubitemid 32852562)
4. Spierings E, Brickner AG, Caldwell JA, et al. The minor histocompatibility antigen HA-3 arises from differential proteasome-mediated cleavage of the lymphoid blast crisis (Lbc) oncoprotein. Blood. 2003;102(2):621-629. (Pubitemid 36841984)
5. Marijt WA, Heemskerk MH, Kloosterboer FM, et al. Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia. Proc Natl Acad Sci U S A. 2003;100(5):2742-2747.
6. Falkenburg JH, Marijt WA, Heemskerk MH, Willemze R. Minor histocompatibility antigens as targets of graft-versus-leukemia reactions. Curr Opin Hematol. 2002;9(6):497-502. (Pubitemid 35191118)
7. Kircher B, Stevanovic S, Urbanek M, et al. Induction of HA-1-specific cytotoxic T-cell clones parallels the therapeutic effect of donor lymphocyte infusion. Br J Haematol. 2002;117(4):935-939. (Pubitemid 34639258)
8. Voogt PJ, Goulmy E, Veenhof WF, et al. Cellularly defined minor histocompatibility antigens are differentially expressed on human hematopoietic progenitor cells. J Exp Med. 1988;168(6):2337-2347. (Pubitemid 19020909)
9. Miklos DB, Kim HT, Miller KH, et al. Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission. Blood. 2005;105(7):2973-2978.
10. Preuss KD, Zwick C, Bormann C, Neumann F, Pfreundschuh M. Analysis of the B-cell repertoire against antigens expressed by human neoplasms. Immunol Rev. 2002;188:43-50. (Pubitemid 35398864)
11. Bellucci R, Wu CJ, Chiaretti S, et al. Complete response to donor lymphocyte infusion in multiple myeloma is associated with antibody responses to highly expressed antigens. Blood. 2004;103(2):656-663. (Pubitemid 38140101)
12. Wu CJ, Yang XF, McLaughlin S, et al. Detection of a potent humoral response associated with immune-induced remission of chronic myelogenous leukemia. J Clin Invest. 2000;106(5):705-714. (Pubitemid 30691342)
13. Pfistershammer K, Majdic O, Stockl J, et al. CD63 as an activation-linked T cell costimulatory element. J Immunol. 2004;173(10):6000-6008. (Pubitemid 39487754)
14. Bartel G, Wahrmann M, Exner M, et al. In vitro detection of C4d-fixing HLA alloantibodies: associations with capillary C4d deposition in kidney allografts. Am J Transplant. 2008;8(1):41-49.
15. Steinberger P, Majdic O, Derdak SV, et al. Molecular characterization of human 4Ig-B7-H3, a member of the B7 family with four Ig-like domains. J Immunol. 2004;172(4):2352-2359. (Pubitemid 38182383)
16. Kober J, Leitner J, Klauser C, et al. The capacity of the TNF family members 4-1BBL, OX40L, CD70, GITRL, CD30L and LIGHT to costimulate human T cells. Eur J Immunol. 2008;38(10):2678-2688.
17. Pfistershammer K, Klauser C, Leitner J, et al. Identification of the scavenger receptors SREC-I, Cla-1 (SR-BI), and SR-AI as cellular receptors for Tamm-Horsfall protein. J Leukoc Biol. 2008;83(1):131-138.
18. Dietrich J, Nakajima H, Colonna M. Human inhibitory and activating Ig-like receptors which modulate the function of myeloid cells. Microbes Infect. 2000;2(3):323-329. (Pubitemid 30167667)
19. Colonna M, Navarro F, Bellon T, et al. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J Exp Med. 1997;186(11):1809-1818. (Pubitemid 27524591)
20. National Center for Biotechnology Information, GenBank. http://www.ncbi.nlm.nih.gov/Genbank. Accessed June 10, 2008.
21. Goulmy E, Schipper R, Pool J, et al. Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation. N Engl J Med. 1996;334(5):281-285. (Pubitemid 26033083)
22. de Rijke B, van Horssen-Zoetbrood A, Beekman JM, et al. A frameshift polymorphism in P2X5 elicits an allogeneic cytotoxic T lymphocyte response associated with remission of chronic myeloid leukemia. J Clin Invest. 2005;115(12):3506-3516.
23. Mutis T, Gillespie G, Schrama E, Falkenburg JH, Moss P, Goulmy E. Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease. Nat Med. 1999;5(7):839-842. (Pubitemid 29318622)
24. Dickinson AM, Wang XN, Sviland L, et al. In situ dissection of the graft-versus-host activities of cytotoxic T cells specific for minor histocompatibility antigens. Nat Med. 2002;8(4):410-414. (Pubitemid 34407038)
25. Tseng LH, Lin MT, Hansen JA, et al. Correlation between disparity for the minor histocompatibility antigen HA-1 and the development of acute graft-versus-host disease after allogeneic marrow transplantation. Blood. 1999;94(8):2911-2914.
26. Warren EH, Gavin M, Greenberg PD, Riddell SR. Minor histocompatibility antigens as targets for T-cell therapy after bone marrow transplantation. Curr Opin Hematol. 1998;5(6):429-433. (Pubitemid 28521513)
27. Miklos DB, Kim HT, Zorn E, et al. Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donors. Blood. 2004;103(1):353-359. (Pubitemid 38035116)
28. Trowsdale J, Barten R, Haude A, Stewart CA, Beck S, Wilson MJ. The genomic context of natural killer receptor extended gene families. Immunol Rev. 2001;181:20-38. (Pubitemid 32703393)
29. Shiroishi M, Tsumoto K, Amano K, et al. Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G. Proc Natl Acad Sci U S A. 2003;100(15):8856- 8861. (Pubitemid 36899188)
30. Chang CC, Ciubotariu R, Manavalan JS, et al. Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4. Nat Immunol. 2002;3(3):237-243. (Pubitemid 34218114)
31. Shiroishi M, Kuroki K, Rasubala L, et al. Structural basis for recognition of the nonclassical MHC molecule HLA-G by the leukocyte Ig-like receptor B2 (LILRB2/LIR2/ILT4/CD85d). Proc Natl Acad Sci U S A. 2006;103(44):16412-16417. (Pubitemid 44715210)
32. Su AI, Wiltshire T, Batalov S, et al. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci U S A. 2004;101(16):6062- 6067. (Pubitemid 38520528)
33. Maruya E, Saji H, Seki S, et al. Evidence that CD31, CD49b, and CD62L are immunodominant minor histocompatibility antigens in HLA identical sibling bone marrow transplants. Blood. 1998;92(6):2169-2176. (Pubitemid 28446709)
34. Bellucci R, Alyea EP, Chiaretti S, et al. Graft-versus-tumor response in patients with multiple myeloma is associated with antibody response to BCMA, a plasma-cell membrane receptor. Blood. 2005;105(10):3945-3950. (Pubitemid 40656141)